Evidence map›Paper›PMID 41507300›Full record

ArticleScientific reports2026

Exploring the potential of SnO

Firouzeh Salimian, Alireza Hemmati, Ahad Ghaemi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Firouzeh SalimianSchool of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Narmak, Tehran, P.O. Box: 16765-163, Iran.
Alireza HemmatiSchool of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Narmak, Tehran, P.O. Box: 16765-163, Iran.
Ahad GhaemiSchool of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Narmak, Tehran, P.O. Box: 16765-163, Iran. aghaemi@iust.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the properties of SnO2 nanomaterials as CO2 adsorbents. Although CO2 capture technologies have significantly advanced, challenges such as high costs and limited scalability persist. In recent years, nanomaterials have emerged as promising candidates for CO2 adsorption due to their high adsorption capacity, lower cost, and wide availability. However, future research should focus on developing low-cost and efficient nanomaterials to enable large-scale industrial CO2 capture. This study examined the CO2 adsorption capacity using SnO2 nanoadsorbents by employing response surface methodology (RSM) and artificial neural networks (ANNs), specifically radial basis function (RBF) and multilayer perceptron (MLP) networks, for process modeling and optimization. Through the analysis of experimental data, temperature, pressure, and adsorption time were identified as crucial influencing factors. The R2 value of 0.9933 for RSM indicated a great match, whereas the R2 value of one for ANNs indicated superior predictive accuracy. With a minimum mean squared error (MSE) of 0.00012 for the dataset, the MLP was trained using a three-layer activation function. With 288 neurons and a spread of 2, the RBF network achieved an R2 value of 0.9985 and a minimal MSE of 0.00075. The smooth MLP plots effectively captured complex discontinuities, showcasing the superior predictive abilities of ANNs for optimizing the CO2 adsorption process using SnO2 nanoadsorbents, while the RSM surfaces exhibited rigid, polynomial-based patterns.

Indexed as

ANNCO2Metal oxideNanomaterialsRSMSnO2

Identifiers

PMID41507300
PMCPMC12864843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.